Breast Center of Excellence, Naef K. Basile Cancer Institute and Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
J Thorac Dis. 2013 Jun;5 Suppl 1(Suppl 1):S2-8. doi: 10.3978/j.issn.2072-1439.2013.05.24.
Breast cancer is the most common malignancy in women with 6.6% of cases diagnosed in young women below the age of 40. Despite variances in risk factors, Age Standardized Incidence Rates of breast cancer in young women vary little between different countries. Review of modifiable risk factors shows that long-term use of oral contraceptives, low body mass index (BMI) and high animal fat diet consumption are associated with increased risk of premenopausal breast cancer. Decreased physical activity and obesity increase risks of breast cancer in postmenopausal women, but data on premenopausal women rather shows that high BMI is associated with decreased risk of breast cancer. Non-modifiable risk factors such as family history and genetic mutations do account for increased risks of breast cancer in premenopausal women. Breast cancer in young women is associated with adverse pathological factors, including high grade tumors, hormone receptor negativity, and HER2 overexpression. This has a significant negative impact on the rate of local recurrence and overall survival. Moreover, younger women often tend to present with breast cancer at a later stage than their older counterparts, which further explains worse outcome. Despite these factors, age per se is still being advocated as an independent role player in the prognosis. This entails more aggressive treatment modalities and the need for closer monitoring and follow-up.
乳腺癌是女性最常见的恶性肿瘤,6.6%的病例发生在 40 岁以下的年轻女性中。尽管危险因素存在差异,但不同国家年轻女性乳腺癌的年龄标准化发病率差异不大。对可改变的危险因素进行回顾显示,长期使用口服避孕药、低体重指数(BMI)和高脂肪饮食与绝经前乳腺癌风险增加有关。体力活动减少和肥胖会增加绝经后女性患乳腺癌的风险,但关于绝经前女性的数据表明,高 BMI 与乳腺癌风险降低有关。不可改变的危险因素,如家族史和基因突变,确实会增加绝经前女性患乳腺癌的风险。年轻女性的乳腺癌与不良的病理因素有关,包括高分级肿瘤、激素受体阴性和 HER2 过表达。这对局部复发率和总生存率有显著的负面影响。此外,年轻女性往往比年长女性更晚出现乳腺癌,这进一步解释了较差的预后。尽管存在这些因素,但年龄本身仍被认为是预后的一个独立影响因素。这需要更积极的治疗方式,以及更密切的监测和随访。